Antigen-presenting cells in human immunosuppressive drug-induced gingival enlargement

Special Care in Dentistry

Volumn 29, Issue 2, 2009, Pages 80-84

  Cury, Patricia R ^a   Arsati, Franco ^a   De Magalhães, Marina Helena Cury Gallottini ^b   De Araújo, Vera C ^a   De Araújo, Ney S ^b   Barbuto, José Alexandre ^b  

^a SÃO LEOPOLDO MANDIC INSTITUTE AND RESEARCH CENTER   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Dendritic cell; Immunosuppressive drug induced gingival enlargement; Macrophage; Periodontal tissues

Indexed keywords

BLOOD CLOTTING FACTOR 13A; CD1 ANTIGEN; CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; IMMUNOSUPPRESSIVE AGENT; LEUKOCYTE ANTIGEN; T6 ANTIGEN;

ADULT; ANTIGEN PRESENTING CELL; ARTICLE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DENDRITIC CELL; ENZYME IMMUNOASSAY; EPITHELIUM; FEMALE; GINGIVA HYPERTROPHY; GINGIVITIS; HUMAN; IMMUNOLOGY; LANGERHANS CELL; MACROPHAGE; MALE; MIDDLE AGED; PATHOLOGY; PERIODONTITIS; PERIODONTIUM;

ADULT; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; ANTIGENS, CD1; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; DENDRITIC CELLS; EPITHELIAL ATTACHMENT; EPITHELIUM; FACTOR XIIIA; FEMALE; GINGIVAL CREVICULAR FLUID; GINGIVAL HYPERTROPHY; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOSUPPRESSIVE AGENTS; LANGERHANS CELLS; MACROPHAGES; MALE; MIDDLE AGED; PERIODONTAL POCKET; PERIODONTIUM;

EID: 68049093043     PISSN: 02751879     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1754-4505.2008.00067.x     Document Type: Article

References (42)

1. Trackman PC, Kantarci A. Connective tissue metabolism and gingival overgrowth. Crit Rev Oral Biol Med 2004;15:165-175
2. Kardachi BJ, Newcomb GM. A clinical study of gingival inflammation in renal transplant recipients taking immunosuppressive drugs. J Periodontol 1978;49:307-309
3. Been V, Engel D. The effects of immunosup- pressive drugs on periodontal inflammation in human renal allograft patients. J Periodontol 1982;53:245-248
4. Tollefsen T, Koppang HS, Messelt E. Immunosuppression and periodontal disease in man. Histological and ultrastructural observations. J Periodontal Res 1982;17:329-344
5. Yamalik N, Delilbasi L, Gulay H, et al. The histological investigation of gingiva from patients with chronic renal failure, renal transplants, and periodontitis: a light and electron microscopic study. J Periodontol 1991;62:737-744
6. Rahman MM, Caglayan F, Rahman B. Periodontal health parameters in patients with chronic renal failure and renal transplants receiving immunosuppressive therapy. J Nihon Univ Sch Den 1992;34:265-272
7. Sutton RB, Smales FC. Cross-sectional study of the effects of immunosuppressive drugs on chronic periodontal disease in man. J Clin Periodontol 1983;10:317-326
8. Oshrain HI, Telsey B, Mandel ID. A longitudinal study of periodontal disease in patients with reduced immunocapacity. J Periodontol 1983;54:151-154
9. Tollefsen T, Johansen JR. The periodontal status of prospective and renal transplant patients. Comparison with systemically healthy patients. J Periodontal Res 1985;20:220-226
10. Pernu HE, Knuuttila ML. Macrophages and lymphocyte subpopulations in nifedipine- and cyclosporine A-associated human gingi- val overgrowth. J Periodontol 2001;72:160-166
11. Nurmenniemi PK, Pernu HE, Laukkanen P, Knuuttila ML. Macrophage subpopulations in gingival overgrowth induced by nifedip- ine and immunosuppressive medication. J Periodontol 2002;73:1323-1330
12. Uzel MI, Kantarci A, Hong HH, et al. Connective tissue growth factor in drug- induced gingival overgrowth. J Periodontol 2001;72:921-931
13. Nurmenniemi PK, Pernu HE, Knuuttila ML. Density of CD1a-labeled Langerhans' cells in normal human gingiva and in nifedipine- and immunosuppressive medication-induced gingival overgrowth. J Periodontol 1999;70:752-756
14. Bulut S, Alaaddinoglu EE, Bilezikci B, et al. Immunohistochemical analysis of lymphocyte subpopulations in cyclosporin A-induced gingival overgrowth. J Periodontol 2002;73:892-899
15. Nurmenniemi PK, Pernu HE, Knuuttila ML. Mast cell subpopulations in gingival overgrowth induced by immunosuppressive and nifedipine medication. J Periodontol 2004;75:933-938
16. Saether K, Tollefsen T, Helgeland K, Schenck K. The gingival plasma cell infiltrate in renal transplant patients on an immunosuppres- sive regimen. Acta Odontol Scand 1998;56:281-287
17. Flaminio MJ, Borges AS, Nydam DV, et al. The effect of CpG-ODN on antigen presenting cells of the foal. J Immune Based Ther Vaccines 2007;5:1. DOI: 10.1186/1476-8518-5-1.
18. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-252
19. Steinman RM, Pack M, Inaba K. Dendritic cells in the T-cell areas of lymphoid organs. Immunol Rev 1997;156:25-37.
20. Neutra MR. Current concepts in mucosal immunity. V Role of M cells in transepithe- lial transport of antigens and pathogens to the mucosal immune system. Am J Physiol 1998;274G:785-791
21. Steinman RM, Pack M, Inaba K. Dendritic cell development and maturation. Adv Exp Med Biol 1997;417:1-6.
22. Caux C, Massacrier C, Vanbervliet B, et al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulo- cyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis. Blood 1997;90:1458-1470
23. Haverson K, Riffault S. Antigen presenting cells in mucosal sites of veterinary species. Vet Res 2006;37:339-358
24. Pozzi LA, Maciaszek JW, Rock KL. Both dendritic cells and macrophages can stimulate naive CD8 T cells in vivo to proliferate, develop effector function, and differentiate into memory cells. J Immunol 2005;175:2071-2081
25. Jotwani R, Palucka AK, Al-Quotub M, et al. Mature dendritic cells infiltrate the T cell- rich region of oral mucosa in chronic periodontitis: in situ, in vivo, and in vitro studies. J Immunol 2001;167:4693-4700
26. Metcalfe SM, Richards FM. Cyclosporine, FK506, and rapamycin. Some effects on early activation events in serum-free, mito- gen-stimulated mouse spleen cells. Transplantation 1990;49:798-802.
27. Kang K, Kubin M, Cooper KD, et al. IL-12 synthesis by human Langerhans cells. J Immunol 1996;156:1402-1407
28. Atilla G, Kutukculer N. Crevicular fluid interleukin-1beta, tumor necrosis factor- alpha, and interleukin-6 levels in renal transplant patients receiving cyclosporine A. J Periodontol 1998;69:784-790
29. Lago E, Carneiro E, Cuzzi T, et al. Clinical and immunohistochemical assessment of the effect of cyclosporin in keratinocytes and dermal dendrocytes in psoriasis. J Cutan Pathol 2007;34:15-21.
30. Williamson MS, Miller EK, Plemons J, et al. Cyclosporine A upregulates interleukin-6 gene expression in human gingiva: possible mechanism for gingival overgrowth. J Periodontol 1994;65:895-903.
31. Nares S, Ng MC, Dill RE, et al. Cyclosporine A upregulates platelet-derived growth factor B chain in hyperplastic human gingiva. J Periodontol 1996;67:271-278
32. Plemons JM, Dill RE, Rees TD, et al. PDGF-B producing cells and PDGF-B gene expression in normal gingival and cyclosporine A-induced gingival overgrowth. J Periodontol 1996;67:264-270
33. Buduneli N, Kutukculer N, Aksu G, Atilla G. Evaluation of transforming growth factor- beta 1 level in crevicular fluid of cyclosporin A-treated patients. J Periodontol 2001;72:526-531
34. Nickoloff BJ, Karabin GD, Barker JN, et al. Cellular localization of interleukin-8 and its inducer, tumor necrosis factor- alpha in psoriasis. Am J Pathol 1991;138:129-140
35. Meikle MC, Atkinson SJ, Ward RV, et al. Gingival fibroblasts degrade type I collagen films when stimulated with tumor necrosis factor and interleukin 1: evidence that breakdown is mediated by metallopro- teinases. J Periodontal Res 1989;24:207-213
36. Iwabuchi S. Hepatic fibrosis and coagulation factor XIII. Nippon Shokakibyo Gakkai Zasshi 1983;80:2229-2239
37. Shizawa Y. The healing process of peptic ulcer and coagulation factor XIII. Nippon Shokakibyo Gakkai Zasshi 1984;81:1559-1568
38. Toida M, Takeuchi J, Sobue M, et al. Histochemical studies on pseudocysts in adenoid cystic carcinoma of the human salivary gland. Histochem J 1985;17:913-924
39. Kunisch E, Fuhrmann R, Roth A, et al. Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochem- istry and flow cytometry. Ann Rheum Dis 2004;63:774-784
40. Falini B, Flenghi L, Pileri S, et al. PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage- restricted form of the CD68 molecule. Am J Pathol 1993;142:1359-1372
41. Seguier S, Gogly B, Bodineau A, et al. Is collagen breakdown during periodontitis linked to inflammatory cells and expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gingival tissue? J Periodontol 2001;72:1398-1406
42. Shah PK, Falk E, Badimon JJ, et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 1995;92:1565-1569